MedTrace Logo

Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)

NCT05886309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2025-04-15

No results posted yet for this study

Summary

The study will explore the performance of the CDMS (Cryo Detector Mass Spectrometer) method in measuring SF (serum ferritin) in human serum of healthy individuals. This will be the first experience of testing SF with this method using biologic material of human origin.

Conditions

  • Serum Ferritin

Interventions

DIAGNOSTIC_TEST

Collection of Blood samples

The following samples will be drawn from each study participant immediately after the venipuncture performed for the whole blood donation: * 1 sample with no anticoagulant (5 ml) for SF measurement with the CDMS method * 1 EDTA (Ethylendiamintetraazetat) sample (7,5 ml) for a complete blood count with red blood cell indices and reticulocytes * 1 EDTA sample (2,7 ml) for the measurement of hepcidin * 1 Li-Heparin-Gel sample (4.7 ml) for the measurement of SF with the ECLIA (Electrochemiluminescence-enzymeimmunoassay) and of the complete set of iron biomarkers (Transferrin Saturation, serum iron, Soluble Transferrin Receptor) * 1 Li-Heparin-Gel sample (4.7 ml) for the measurement of CRP (C-reactive Protein) * 1 sample with no anticoagulant (5 ml) for the measurement of SF with the CMIA (Chemiluminescence Immunoassay) * 1 sample with no anticoagulant (5 ml) for storage

Sponsors & Collaborators

  • Metromol SA

    collaborator UNKNOWN

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Laura Infanti, PD Dr. med. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-03-05
Completion
2024-05-05

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05886309 on ClinicalTrials.gov